News | September 28, 2022
LISSUN raises ~$1 million in pre-Seed round from IvyCap Ventures and others
Funds raised will be used to develop technology and foster healthcare partnerships
Funds raised will be used to develop technology and foster healthcare partnerships
The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses
The #Heart2HeartChallengeIndia campaign is very simple – you have to climb 60 steps in a minute, make a video of it, share it on your social media, tag 5 people, inviting them to take this challenge to check their heart health
The startup plans to provide free technology to dental clinics upon registration.
To set up 50 lifestyle modification centres across the UAE in the next 24 months
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Subscribe To Our Newsletter & Stay Updated
